First line crizotinib in anaplastic lymphoma kinase (ALK) rearranged squamous cell lung cancer
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Pulmonary and Respiratory Medicine,Oncology
Reference9 articles.
1. First-line crizotinib versus chemotherapy in ALK-positive lung cancer;Solomon;N. Engl. J. Med.,2014
2. Clarifying the spectrum of driver oncogene mutations in biomarker-verified squamous carcinoma of lung: lack of EGFR/KRAS and presence of PIK3CA/AKT1 mutations;Rekhtman;Clin. Cancer Res.,2012
3. Squamous cell carcinoma of the lung: molecular subtypes and therapeutic opportunities;Perez-Moreno;Clin. Cancer Res.,2012
4. Identification of enriched driver gene alterations in subgroups of non-small cell lung cancer patients based on histology and smoking status;An;PLoS One,2012
5. Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK;Shaw;J. Clin. Oncol.,2009
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Efficacy analysis of ALK inhibitors for treating lung squamous carcinoma patients harboring ALK rearrangement;Journal of Thoracic Disease;2024-07
2. Analysis of the Efficacy of Afat-inib in the Treatment of ALK-Positive Squamous Cell Carcinoma;Asian Case Reports in Oncology;2022
3. Efficacy and Drug Resistance Analysis of ALK Inhibitors in Combination with Stereotactic Body Radiation Therapy for Treating Lung Squamous Carcinoma Patient Harboring EML4-ALK Rearrangement;OncoTargets and Therapy;2021-12
4. Brigatinib treated ALK positive lung squamous cell carcinoma after failed chemotherapy: A case report;Thoracic Cancer;2021-10-13
5. Dramatic response to alectinib in a patient with ALK ‐rearranged squamous cell lung cancer;Thoracic Cancer;2021-07-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3